revumenib
syndax pharma
['augment,trial', 'augment-101', 'leukemia']
#ash22 abstract 63: our dr. ghayas issa presents updated results from augment-101 trial, which show targeting menin induces response in certain types of acute leukemia: #leukemia #endcancer 
MD Anderson is a global leader in cancer care, research, education and training, and prevention. Appointments available: 1-877-632-6789